{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:31:38Z","timestamp":1759962698656,"version":"3.37.3"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81574029"],"award-info":[{"award-number":["81574029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Allergic conjunctivitis (AC) is a multifactorial and common type of ocular surface disease that affects many people. The quality of life for AC patients can be significantly decreased caused by symptoms of ocular itching, swelling, redness, and tearing. Topical antihistaminics, mast cell stabilizers, non-steroidal anti-inflammatory drugs (NSAIDs), and steroids have been widely used to treat AC. Many clinical trials have indicated that olopatadine hydrochloride eye drops can provide quick relief of symptoms and signs. The purpose of this review is to evaluate systematically the effectiveness of olopatadine hydrochloride eye drops for treating AC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic review of all of the randomized controlled trials on the effectiveness and safety of olopatadine hydrochloride eye drops for AC will be conducted. We will search PubMed, Web of Science (WOS), EMBASE (OVID), the Cochrane Library, Google Scholar, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal database (VIP), Wanfang Database, and CBM, from the database inception date to October 31, 2019. There are no language or publication status restrictions. Registers of clinical trials, potential gray literature, reference lists of studies, and conference abstracts will also be searched. Two reviewers will independently read the articles, extract the data information, and assess the quality of the studies. Data will be synthesized by a heterogeneity test. The primary outcomes include the main symptom and sign scores before and after treatment, the eye redness index, the presence of eosinophils in the conjunctival scraping. Quality of life, the total treatment efficacy, and safety will be evaluated as the secondary outcomes. RevMan V.5.3 software will be used for the meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study will provide an objective and normative systematic review to evaluate the effectiveness and safety of olopatadine hydrochloride eye drops for the treatment of AC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our review will provide useful information to judge whether olopatadine hydrochloride eye drops is an effective intervention for patients with AC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>It is not necessary to obtain ethical approval as participants are not involved patients. The protocol and results will be published in a peer-reviewed journal. The systematic review will also be disseminated electronically and in print to help guide health care practice and policy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Prospero registration number:<\/jats:title>\n            <jats:p>PROSPERO CRD42019132232.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018618","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:10:43Z","timestamp":1581538243000},"page":"e18618","source":"Crossref","is-referenced-by-count":4,"title":["The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis"],"prefix":"10.1097","volume":"99","author":[{"given":"Yingxin","family":"Zi","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Ji","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Qin","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luqi","family":"Nong","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,2]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.alit.2016.12.004","article-title":"Japanese guidelines for allergic conjunctival diseases 2017","volume":"66","author":"Takamura","year":"2017","journal-title":"Allergol Int"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/ACI.0b013e328364ec3a","article-title":"Allergic conjunctivitis: an update on diagnosis and management","volume":"13","author":"O\u2019Brien","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2500\/aap.2015.36.3861","article-title":"Allergic conjunctivitis: time for a new classification","volume":"36","author":"La Rosa","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5415\/apallergy.2017.7.2.57","article-title":"Allergic conjunctivitis in Asia","volume":"7","author":"Thong","year":"2017","journal-title":"Asia Pac Allergy"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1365-2222.2012.04025.x","article-title":"Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States","volume":"42","author":"Maspero","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/ACI.0000000000000311","article-title":"Allergic manifestations of contact lens wearing","volume":"16","author":"Solomon","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ACI.0000000000000205","article-title":"Environmental aeroallergens and allergic rhino-conjunctivitis","volume":"15","author":"Jalbert","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"(1 suppl 1)","key":"R9-20230915","first-page":"49","article-title":"Allergic conjunctivitis: current concepts on pathogenesis and management","volume":"32","author":"Sacchetti","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1517\/14656566.2015.1040760","article-title":"Advances in pharmacotherapy for allergic conjunctivitis","volume":"16","author":"Abelson","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/14728214.2014.902443","article-title":"Emerging drugs for allergic conjunctivitis","volume":"19","author":"Ridolo","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1755-3768.2011.02272.x","article-title":"Management of seasonal allergic conjunctivitis: guide to therapy","volume":"90","author":"Bielory","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"R13-20230915","first-page":"MC04","article-title":"Olopatadine hydrochloride and fluticasone propionate in topical treatment of allergic rhinitis: a single blind randomised study","volume":"10","author":"Havle","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000456009","article-title":"Self-reported allergic rhinitis and\/or allergic conjunctivitis associate with IL13 rs20541 polymorphism in Finnish adult asthma patients","volume":"172","author":"\u00c5djers","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"R16-20230915","first-page":"1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R18-20230915","first-page":"1508","article-title":"Investigation of possible risk factors in the development of seasonal allergic conjunctivitis","volume":"11","author":"Do\u011fan","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3892\/etm.2017.4364","article-title":"A novel noninvasive ocular surface analyzer for the assessment of dry eye with Meibomian gland dysfunction","volume":"13","author":"Qi","year":"2017","journal-title":"Exp Ther Med"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/bmm-2017-0124","article-title":"Biomarkers of ocular surface disease using impression cytology","volume":"11","author":"Hagan","year":"2017","journal-title":"Biomark Med"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2046-4053-3-37","article-title":"Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation","volume":"3","author":"Savovi\u0107","year":"2014","journal-title":"Syst Rev"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13643-017-0630-4","article-title":"Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes","volume":"6","author":"Chen","year":"2017","journal-title":"Syst Rev"},{"key":"R24-20230915","first-page":"1","article-title":"The method quality of cross-over studies involved in Cochrane Systematic Reviews","volume":"10","author":"Ding","year":"2015","journal-title":"PLoS One"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R26-20230915","first-page":"1","article-title":"Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis","volume":"1","author":"Castillo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20230915","first-page":"315","article-title":"What is the most effective topical treatment for allergic conjunctivitis?","volume":"64","author":"Schulz","year":"2015","journal-title":"J Fam Pract"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/ICO.0000000000000247","article-title":"Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis","volume":"33","author":"Ghanem","year":"2014","journal-title":"Cornea"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/09273948.2016.1158282","article-title":"Topical olopatadine in the treatment of allergic conjunctivitis: a systematic review and meta-analysis","volume":"25","author":"Kam","year":"2017","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:10:47Z","timestamp":1694819447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018618"}},"subtitle":["Protocol for a systematic review"],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018618","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}